Grass Roots Events 2022
View our list of Grass Roots events in 2022 and find an event near you.
Szukaj
Trzoda chlewna
Trzoda chlewna
Open Innovation at Boehringer Ingelheim
Learn more about how we’re working across the innovation community to advance research and accelerate the development of new medicines
Our Partners Harvard
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
View from Both Sides of the Table
Stawiamy na zarządzanie aliansami
Kodeks postępowania dostawców
BI’s expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
Equestrian sports technology
Learn about new trends in equine health and get insights into the human-horse relationship!
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Mutual benefit: Patient-centricity in clinical trials
Uli Broedl and Bronwyn Lewis share what they learnt from a successful patient organization collaboration on clinical trial design.
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Historia Boehringer Ingelheim w latach 1948-1990,
Historia Boehringer Ingelheim w latach 1948-1990, z kamieniami milowymi
Historia (1885-1948): Nowatorskie początki
Historia Boehringer Ingelheim od rozpoczęcia działalności w 1885 roku do 1948 roku, z kamieniami milowymi i ważnymi produktami
1990-2022: Wartość dzięki innowacjom
The Boehringer Ingelheim history from 1990 to 2022, with milestones
Championing novel science
Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
Advancing regenerative medicine
Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Światowy Dzień Chorób Rzadkich 2021
Rzadkie, ale nie zapomniane: dlaczego wsparcie medyczne dla około 30 milionów osób w UE cierpiących na choroby rzadkie1 jest nie do przecenienia
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Stem cells a new frontier
Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
Być niezależnym
Kultura korporacyjna Boehringer Ingelheim opiera się na wartościach, które są stosowane od momentu założenia firmy w 1885 roku.
Women in STEM 2022
Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM.
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE
Empagliflozyna zatwierdzona do leczenia osób dorosłych z przewlekłą chorobą nerek w UE